Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06990191 · ClinicalTrials.gov registry record · NA
A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD
A NA study of Post Traumatic Stress Disorder, sponsored by United States Department of Defense.
- Recruiting
- Registry status
- NA
- Development phase
- 420
- Enrollment target
- 4
- Study locations
NCT06990191: Recruiting NA study of Post Traumatic Stress Disorder, sponsored by United States Department of Defense.
NCT06990191 is a NA study of Post Traumatic Stress Disorder that is actively recruiting participants, run by United States Department of Defense. The registered enrollment target is 420 participants, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (37% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06990191, a NA study of Post Traumatic Stress Disorder, is actively recruiting participants, sponsored by United States Department of Defense.
- RECRUITING
- Registry status
- NA
- Development phase
- 420 participants
- Enrollment target
- 4
- Study locations
Study Summary
PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are not equally effective for everyone. An important minority (\~40%) will retain their PTSD diagnoses after treatment, and many discontinue treatment prematurely, especially post-9/11 Service Members. TFTs are also more effective in addressing symptoms than psychosocial functioning. More work is needed to improve the consistency and potency of TFTs. Partnering with significant others may provide a powerful method for helping individuals get more out of their PTSD treatment. Observational research shows that relationship factors can help patients initiate, stay in, and experience greater benefit from PTSD treatment. Veterans that were surveyed experienced greater treatment gains when they shared more about their treatment with loved ones and when loved ones accommodated less for PTSD symptoms. Despite the promise of partner-involved interventions, there is no couples approach to PTSD treatment that has demonstrated superior outcomes to individual-only treatment models (i.e., TFTs). To address this gap, the investigators have completed a series of partner-assisted PTSD treatment studies, leading up the current proposal (Partnered PE, PPE). The investigators found that treatment completion rates were better than routine clinical care, and the treatment led to large improvements in participants' functioning, PTSD symptoms, and romantic functioning. For this proposed study, the primary objective is to conduct a randomized controlled trial (Research Level 3; larger-scale clinical trial) to test the superiority of PPE to standard PE among post 9/11 Veterans. The investigator's primary hypothesis is that PPE will lead to greater improvements in psychosocial functioning than standard PE. Secondary and t
Primary Outcome
The primary outcome is Veterans' global functioning at posttreatment assessment. The subdimensions of global functioning that matter most to Veterans with PTSD are their relationships with intimate partners, family relationships, work performance, friend relationships, parenting, educational performance, and self-care functioning (e.g., maintaining personal hygiene, exercising, household chores, healthy eating). Outcomes will be measured using the Inventory of Psychosocial Functioning (IPF).
Conditions Studied
Interventions
- BEHAVIORAL Partnered Prolonged Exposure (PPE)
- BEHAVIORAL Prolonged Exposure (PE)
Study Locations (4)
Arizona
- Phoenix VA Healthcare System - Phoenix
California
- San Diego VA Healthcare System - San Diego
Minnesota
- Minneapolis VA Healthcare System - Minneapolis
South Carolina
- Charleston VA Healthcare System - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 420 participants |
| Start Date | 2025-05-16 |
| Est. Completion | 2028-08-31 |
| Phase | NA |
What NCT06990191 shows while recruiting
NCT06990191 is an interventional study that assigns participants to a tested intervention. The registered 420 participants enrollment target is mid-sized for trials with a published cap, below the 662-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (37% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Partnered Prolonged Exposure (PPE) is the first listed.
NCT06990191 reports a single indexed study location in Arizona, California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06990191 about?
NCT06990191 is a clinical study titled "A Hybrid 1 Effectiveness-Implementation Trial of Partner-Assisted Prolonged Exposure for PTSD". PTSD occurs in up to 17% of post-9/11 US Service Members and is associated with long-term functional impairment, family problems, unemployment, and suicidality. Trauma-focused therapies (TFTs), such as Prolonged Exposure (PE), result in significant relief for many. Yet, TFTs are not equally effectiv...
What is the current status of trial NCT06990191?
This trial is currently recruiting. It is a NA study. The enrollment target is 420 participants. The study started on 2025-05-16. Estimated completion is 2028-08-31.
What conditions does trial NCT06990191 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT06990191?
The interventions under investigation include: Partnered Prolonged Exposure (PPE) (BEHAVIORAL), Prolonged Exposure (PE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06990191?
This trial is sponsored by United States Department of Defense, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06990191 being conducted?
This trial has 4 study locations across Arizona, California, Minnesota, South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06990191's enrollment target sits among peer trials
420 16th of 262 higher than 247 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
- NCT04149743 · 420 participants · NA
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI